Updated Jul 16, 2026
Samuel George A. III is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $9K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-14 | LCTX | Lineage Cell Therapeutics, Inc. | F — Tax withholding / forfeiture | 2.5K | $1.80 | $5K |
| 2026-02-14 | LCTX | Lineage Cell Therapeutics, Inc. | M — Option exercise | 6.1K | — | |
| 2025-12-20 | LCTX | Lineage Cell Therapeutics, Inc. | F — Tax withholding / forfeiture | 65 | $1.68 | $109 |
| 2025-12-20 | LCTX | Lineage Cell Therapeutics, Inc. | A — Grant or award | 1.7K | — | |
| 2024-11-26 | LCTX | Lineage Cell Therapeutics, Inc. | P — Open-market purchase | 15.0K | $0.60 | $9K |
Samuel George A. III is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 1 open-market purchases ($9K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Samuel George A. III profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.